Developing state of the art science with the best partners
Carrick Therapeutics is building an innovative portfolio of first-in-class and best-in-class treatments that target multiple mechanisms driving the most aggressive forms of cancer. We work with partners at every stage of the drug discovery process - from the groups we license our assets from, to the contract research organizations and academics with whom we conduct our studies.
Licensing new opportunities
We are actively seeking new assets that are significantly differentiated and have the potential opportunity for being best-in-class. If you would like to explore partnering opportunities with us and understand how our team of leading experts could help advance your asset, please contact email@example.com.